Inventor · disambiguated record

Alexander Smith

Also filed as: SMITH ALEXANDER · SMITH ALEXANDER D · SMITH ALEXANDER V

21 granted patents·16 pending applications·105 citations·filing 2000–2025

94Inventor score

Technology areasA61K C07D A61P C07B C10L

Files withAERPIO THERAPEUTICS INC8 G1 THERAPEUTICS INC6 FENNEC PHARMACEUTICALS INC5 PHARMACOSMOS HOLDING AS4 AKEBIA THERAPEUTICS INC3

Top patents by PatentIndex Score

37 records

0197US9440963B2Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2014·Granted Sep 13, 2016·35 cites·60 claims
0295US12168666B2Morphic forms of trilaciclib and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2021·Granted Dec 17, 2024·8 cites·27 claims
0395US10988479B1Morphic forms of trilaciclib and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2020·Granted Apr 27, 2021·15 cites·14 claims
0494US12139494B2Morphic forms of G1T38 and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2022·Granted Nov 12, 2024·3 cites·1 claims
0594US11992530B2Therapeutic uses for sodium thiosulfate and formulationsFENNEC PHARMACEUTICALS INC·Filed 2022·Granted May 28, 2024·2 cites·26 claims
0693US11261193B2Morphic forms of G1T38 and methods of manufacture thereofG1 THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·5 cites·20 claims
0792US10865210B2Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-aminesG1 THERAPEUTICS INC·Filed 2018·Granted Dec 15, 2020·9 cites·37 claims
0891US11629150B2Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-aminesG1 THERAPEUTICS INC·Filed 2020·Granted Apr 18, 2023·3 cites·5 claims
0988US2025345435A1Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
1086US2025101030A1Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
1184US11998604B2Therapeutic uses for sodium thiosulfate formulationsFENNEC PHARMACEUTICALS INC·Filed 2022·Granted Jun 4, 2024·0 cites·26 claims
1284US11964018B2Therapeutic uses for sodium thiosulfate formulationsFENNEC PHARMACEUTICALS INC·Filed 2022·Granted Apr 23, 2024·0 cites·22 claims
1383US6674487B1Controlling hue using a saturation control circuitINTEL CORP·Filed 2000·Granted Jan 6, 2004·25 cites·18 claims
1482US12152023B2Compositions, formulations and methods for treating ocular diseasesEYEPOINT PHARMACEUTICALS INC·Filed 2022·Granted Nov 26, 2024·0 cites·18 claims
1581US12497404B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Dec 16, 2025·0 cites·11 claims
1681US12479855B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Nov 25, 2025·0 cites·13 claims
1781US12311026B2Therapeutic uses for sodium thiosulfate formulationsFENNEC PHARMACEUTICALS INC·Filed 2024·Granted May 27, 2025·0 cites·26 claims
1877US2025304592A1Morphic forms of g1t38 and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
1973US2020361926A1Compositions, formulations and methods for treating ocular diseasesAERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
2072US2018237429A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
2172US2018237430A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
2272US2018237431A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
2371US2024325361A1Compositions and Methods for Treating AnemiaAKEBIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2470US12467066B2Compositions and methods for treating retinal disordersUCL BUSINESS LTD·Filed 2023·Granted Nov 11, 2025·0 cites·29 claims
2569US2018022741A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
2668US11844756B2Compositions and methods for treating anemiaAKEBIA THERAPEUTICS INC·Filed 2022·Granted Dec 19, 2023·0 cites·18 claims
2768US2018251457A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
2867US2016220540A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
2963US2016220541A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
3060US11680276B2Compositions and methods for treating retinal disordersUCL BUSINESS LTD·Filed 2019·Granted Jun 20, 2023·0 cites·42 claims
3156US2023075630A1Extracellular vesicle-based agents and methods for the treatment of neuropathic disordersUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
3255US11324734B2Compositions and methods for treating anemiaAKEBIA THERAPEUTICS INC·Filed 2016·Granted May 10, 2022·0 cites·8 claims
3351US12480062B2Compositions and methods and uses relating theretoINNOSPEC LTD·Filed 2020·Granted Nov 25, 2025·0 cites·14 claims
3450US2024398773A1Compositions comprising oteseconazoleMYCOVIA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
3549US12305134B2Compositions and methods and uses relating theretoINNOSPEC LTD·Filed 2020·Granted May 20, 2025·0 cites·13 claims
3643US2008039433A1Stabilized Tetracycline CompositionsSMITH ALEXANDER D·Filed 2007·Application pending·0 cites
3732US2008038338A1Tetracycline Package FormulationsSMITH ALEXANDER D·Filed 2007·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Alexander Smith files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →